Skip to main content

Advertisement

SpringerLink
Log in

Transcranial magnetic stimulation for the treatment of depression in neurologic disorders

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Depression is commonly associated with neurologic disorders. Although depression in neurologic conditions often is associated with a negative impact on quality of life, it frequently is poorly managed. Some factors, such as a multidrug regimen, lack of efficacy, and side effects of antidepressants may explain why depression is not adequately treated in patients with neurologic disorders. Therefore, this population needs new approaches for depression treatment, and repetitive transcranial magnetic stimulation (rTMS) may be one of them because it has been shown to be effective for the treatment of depression alone and depression in certain neurologic diseases such as Parkinson’s disease and stroke. rTMS is a noninvasive, focal, and painless treatment associated with few, mild side effects. It may be effective in the treatment of neurologic diseases such as Parkinson’s disease, stroke, and epilepsy. In this paper, we discuss the potential risks and benefits of rTMS treatment for depression in Parkinson’s disease, epilepsy, stroke, multiple sclerosis, and Alzheimer’s disease. Lastly, a framework that includes the parameters of stimulation (intensity, frequency, number of pulses, and site of stimulation) for the treatment of depression in neurologic diseases is proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Pascual-Leone A, Valls-Sole J, Brasil-Neto JP, et al.: Akinesia in Parkinson’s disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology 1994, 44:892–898.

    PubMed  CAS  Google Scholar 

  2. Conca A, Koppi S, Konig P, et al.: Transcranial magnetic stimulation: a novel antidepressive strategy? Neuropsychobiology 1996, 34:204–207.

    PubMed  CAS  Google Scholar 

  3. George MS, Wassermann EM, Kimbrell TA, et al.: Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry 1997, 154:1752–1756.

    PubMed  CAS  Google Scholar 

  4. Koppi S, Conca A, Swoboda E, Konig P: [Transcranial magnetic stimulation in depressed patients: a new antidepressive therapeutic principle? Presentation of a pilot trial]. Wien Med Wochenschr 1996, 146:49–54.

    PubMed  CAS  Google Scholar 

  5. Pascual-Leone A, Rubio B, Pallardo F, Catala MD: Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996, 348:233–237. This is the first double-blind, controlled, randomized clinical trial that evaluated the effects of rTMS treatment on depression. This study shows that rTMS has a significant antidepressant effect in patients with major depression.

    Article  PubMed  CAS  Google Scholar 

  6. Mansur C, Fregni F, Boggio PS, et al.: A sham-stimulation controlled trial of rTMS of the unaffected hemisphere on hand motor function after stroke. Neurology 2005, 64:1802–1804.

    Article  PubMed  CAS  Google Scholar 

  7. Siebner HR, Tormos JM, Ceballos-Baumann AO, et al.: Lowfrequency repetitive transcranial magnetic stimulation of the motor cortex in writer’s cramp. Neurology 1999, 52:529–537.

    PubMed  CAS  Google Scholar 

  8. Fregni F, Thome-Souza S, Bermpohl F, et al.: Antiepileptic effects of repetitive TMS in patients with cortical malformations: an EEG and clinical study. Stereotact Func Neurosurgery 2005, In press.

  9. Menkes DL, Bodnar P, Ballesteros RA, Swenson MR: Right frontal lobe slow frequency repetitive transcranial magnetic stimulation (SF r-TMS) is an effective treatment for depression: a case-control pilot study of safety and efficacy. J Neurol Neurosurg Psychiatry 1999, 67:113–115.

    PubMed  CAS  Google Scholar 

  10. Theodore WH, Hunter K, Chen R, et al.: Transcranial magnetic stimulation for the treatment of seizures: a controlled study. Neurology 2002, 59:560–562.

    PubMed  CAS  Google Scholar 

  11. Brighina F, Piazza A, Vitello G, et al.: rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci 2004, 227:67–71.

    Article  PubMed  Google Scholar 

  12. Hoffman RE, Hawkins KA, Gueorguieva R, et al.: Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry 2003, 60:49–56.

    Article  PubMed  Google Scholar 

  13. McIntosh AM, Semple D, Tasker K, et al.: Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Res 2004, 127:9–17.

    Article  PubMed  Google Scholar 

  14. Schonfeldt-Lecuona C, Gron G, Walter H, et al.: Stereotaxic rTMS for the treatment of auditory hallucinations in schizophrenia. Neuroreport 2004, 15:1669–1673.

    Article  PubMed  Google Scholar 

  15. Kaptsan A, Yaroslavsky Y, Applebaum J, et al.: Right prefrontal TMS versus sham treatment of mania: a controlled study. Bipolar Disord 2003, 5:36–39.

    Article  PubMed  Google Scholar 

  16. Saba G, Rocamora JF, Kalalou K, et al.: Repetitive transcranial magnetic stimulation as an add-on therapy in the treatment of mania: a case series of eight patients. Psychiatry Res 2004, 128:199–202.

    Article  PubMed  Google Scholar 

  17. Cohen H, Kaplan Z, Kotler M, et al.: Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2004, 161:515–524.

    Article  PubMed  Google Scholar 

  18. Martin JL, Barbanoj MJ, Perez V, Sacristan M: Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder. Cochrane Database Syst Rev 2003:CD003387.

  19. Martin JL, Barbanoj MJ, Schlaepfer TE, et al.: Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry 2003, 182:480–491.

    Article  PubMed  Google Scholar 

  20. Lemke MR, Fuchs G, Gemende I, et al.: Depression and Parkinson’s disease. J Neurol 2004, 251(Suppl 6):24–27.

    Google Scholar 

  21. Kanner AM, Soto A, Gross-Kanner H: Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology 2004, 62:708–713.

    PubMed  Google Scholar 

  22. Hackett ML, Yapa C, Parag V, Anderson CS: Frequency of depression after stroke. A systematic review of observational studies. Stroke 2005, 36:1330–1340.

    Article  PubMed  Google Scholar 

  23. Siegert RJ, Abernethy DA: Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005, 76:469–475.

    Article  PubMed  CAS  Google Scholar 

  24. Boland RJ: Depression in Alzheimer’s disease and other dementias. Curr Psychiatry Rep 2000, 2:427–433.

    PubMed  CAS  Google Scholar 

  25. Fregni F, Santos CM, Myczkowski ML, et al.: Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 2004, 75:1171–1174. This is the first relatively large, double-blind, controlled, randomized clinical trial that evaluated rTMS treatment for depression in PD. This study shows that high-frequency rTMS has a significant antidepressant effect in patients with PD.

    Article  PubMed  CAS  Google Scholar 

  26. Jorge RE, Robinson RG, Tateno A, et al.: Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry 2004, 55:398–405. This study reported that high-frequency rTMS is safe and has a significant antidepressant effect in patients with stroke and depression.

    Article  PubMed  Google Scholar 

  27. Daniele O, Brighina F, Piazza A, et al.: Low-frequency transcranial magnetic stimulation in patients with cortical dysplasia - a preliminary study. J Neurol 2003, 250:761–762.

    Article  PubMed  Google Scholar 

  28. Khedr EM, Farweez HM, Islam H: Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinson’s disease patients. Eur J Neurol 2003, 10:567–572.

    Article  PubMed  CAS  Google Scholar 

  29. Mally J, Stone TW: Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation. J Neurol Sci 1999, 162:179–184.

    Article  PubMed  CAS  Google Scholar 

  30. Shimamoto H, Takasaki K, Shigemori M, et al.: Therapeutic effect and mechanism of repetitive transcranial magnetic stimulation in Parkinson’s disease. J Neurol 2001, 248(Suppl_3):III48–52.

    PubMed  Google Scholar 

  31. Dragasevic N, Potrebic A, Damjanovic A, et al.: Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson’s disease: an open study. Mov Disord 2002, 17:528–532.

    Article  PubMed  Google Scholar 

  32. Douyon R, Serby M, Klutchko B, Rotrosen J: ECT and Parkinson’s disease revisited: a “naturalistic” study. Am J Psychiatry 1989, 146:1451–1455.

    PubMed  CAS  Google Scholar 

  33. Elger G, Hoppe C, Falkai P, et al.: Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000, 42:203–210.

    Article  PubMed  CAS  Google Scholar 

  34. Harden CL, Pulver MC, Ravdin LD, et al.: A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 2000, 1:93–99.

    Article  PubMed  Google Scholar 

  35. Eschweiler GW, Wegerer C, Schlotter W, et al.: Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res 2000, 99:161–172.

    Article  PubMed  CAS  Google Scholar 

  36. George MS, Nahas Z, Molloy M, et al.: A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 2000, 48:962–970.

    Article  PubMed  CAS  Google Scholar 

  37. Hausmann A, Kemmler G, Walpoth M, et al.: No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled “add on” trial. J Neurol Neurosurg Psychiatry 2004, 75:320–322.

    PubMed  CAS  Google Scholar 

  38. Loo C, Mitchell P, Sachdev P, et al.: Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry 1999, 156:946–948.

    PubMed  CAS  Google Scholar 

  39. Holtzheimer III PE, Russo J, Avery DH: A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull 2001, 35:149–169.

    PubMed  Google Scholar 

  40. Couturier JL: Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci 2005, 30:83–90.

    PubMed  Google Scholar 

  41. George MS, Wassermann EM, Kimbrell TA, et al.: Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry 1997, 154:1752–1756.

    PubMed  CAS  Google Scholar 

  42. Padberg F, Zwanzger P, Thoma H, et al.: Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res 1999, 88:163–171.

    Article  PubMed  CAS  Google Scholar 

  43. Rumi DO, Gattaz WF, Rigonatti SP, et al.: Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry 2005, 57:162–166.

    Article  PubMed  CAS  Google Scholar 

  44. Fitzgerald PB, Brown TL, Marston NA, et al.: Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 2003, 60:1002–1008.

    Article  PubMed  Google Scholar 

  45. Kauffmann CD, Cheema MA, Miller BE: Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study. Depress Anxiety 2004, 19:59–62.

    Article  PubMed  Google Scholar 

  46. Klein E, Kolsky Y, Puyerovsky M, et al.: Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: a double-blind sham-controlled pilot study. Biol Psychiatry 1999, 46:1451–1454.

    Article  PubMed  CAS  Google Scholar 

  47. Sachdev PS, McBride R, Loo C, et al.: Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats. Biol Psychiatry 2002, 51:474–479.

    Article  PubMed  Google Scholar 

  48. Nahas Z, Teneback CC, Kozel A, et al.: Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J Neuropsychiatry Clin Neurosci 2001, 13:459–470.

    PubMed  CAS  Google Scholar 

  49. Wassermann EM: Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996. Electroencephalogr Clin Neurophysiol 1998, 108:1–16. This is the main study on safety of rTMS. This study summarizes the guidelines for the use of rTMS, recommending limits on stimulation parameters, subjects monitoring and contra-indications to rTMS.

    Article  PubMed  CAS  Google Scholar 

  50. Ikeguchi M, Touge T, Nishiyama Y, et al.: Effects of successive repetitive transcranial magnetic stimulation on motor performances and brain perfusion in idiopathic Parkinson’s disease. J Neurol Sci 2003, 209:41–46.

    Article  PubMed  Google Scholar 

  51. Okabe S, Ugawa Y, Kanazawa I: 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson’s disease. Mov Disord 2003, 18:382–388.

    Article  PubMed  Google Scholar 

  52. Siebner HR, Mentschel C, Auer C, Conrad B: Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson’s disease. Neuroreport 1999, 10:589–94.

    Article  PubMed  CAS  Google Scholar 

  53. Tergau F, Wassermann EM, Paulus W, Ziemann U: Lack of clinical improvement in patients with Parkinson’s disease after low and high frequency repetitive transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol Suppl 1999, 51:281–288.

    PubMed  CAS  Google Scholar 

  54. Cruz-Martinez A, Gonzalez-Orodea JI, Lopez Pajares R, Arpa J: Disability in multiple sclerosis. The role of transcranial magnetic stimulation. Electromyogr Clin Neurophysiol 2000, 40:441–447.

    PubMed  CAS  Google Scholar 

  55. Petajan JH, White AT: Motor-evoked potentials in response to fatiguing grip exercise in multiple sclerosis patients. Clin Neurophysiol 2000, 111:2188–2195.

    Article  PubMed  CAS  Google Scholar 

  56. Ferreri F, Pauri F, Pasqualetti P, et al.: Motor cortex excitability in Alzheimer’s disease: a transcranial magnetic stimulation study. Ann Neurol 2003, 53:102–108.

    Article  PubMed  Google Scholar 

  57. Pepin JL, Bogacz D, de Pasqua V, Delwaide PJ: Motor cortex inhibition is not impaired in patients with Alzheimer’s disease: evidence from paired transcranial magnetic stimulation. J Neurol Sci 1999, 170:119–123.

    Article  PubMed  CAS  Google Scholar 

  58. Chen R, Classen J, Gerloff C, et al.: Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997, 48:1398–1403. This is one of the first studies to show that low-frequency rTMS can decrease cortical excitability in the motor cortex of healthy subjects.

    PubMed  CAS  Google Scholar 

  59. Romero JR, Anschel D, Sparing R, et al.: Subthreshold low frequency repetitive transcranial magnetic stimulation selectively decreases facilitation in the motor cortex. Clin Neurophysiol 2002, 113:101–107.

    Article  PubMed  Google Scholar 

  60. Maeda F, Keenan JP, Tormos JM, et al.: Modulation of corticospinal excitability by repetitive transcranial magnetic stimulation. Clin Neurophysiol 2000, 111:800–805.

    Article  PubMed  CAS  Google Scholar 

  61. Gangitano M, Valero-Cabre A, Tormos JM, et al.: Modulation of input-output curves by low and high frequency repetitive transcranial magnetic stimulation of the motor cortex. Clin Neurophysiol 2002, 113:1249–1257.

    Article  PubMed  Google Scholar 

  62. Pascual-Leone A, Valls-Sole J, Wassermann EM, Hallett M: Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 1994b, 117(Pt 4):847–858.

    Article  Google Scholar 

  63. Robertson EM, Theoret H, Pascual-Leone A: Studies in cognition: the problems solved and created by transcranial magnetic stimulation. J Cogn Neurosci 2003, 15:948–960.

    Article  PubMed  CAS  Google Scholar 

  64. Cummings JL: Depression and Parkinson’s disease: a review. Am J Psychiatry 1992, 149:443–454.

    PubMed  CAS  Google Scholar 

  65. Liu CY, Wang SJ, Fuh JL, et al.: The correlation of depression with functional activity in Parkinson’s disease. J Neurol 1997, 244:493–498.

    Article  PubMed  CAS  Google Scholar 

  66. Starkstein SE, Mayberg HS, Leiguarda R, et al.: A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1992, 55:377–382.

    PubMed  CAS  Google Scholar 

  67. Kuopio AM, Marttila RJ, Helenius H, et al.: The quality of life in Parkinson’s disease. Mov Disord 2000, 15:216–223.

    Article  PubMed  CAS  Google Scholar 

  68. Richard IH: Depression in Parkinson’s disease. Curr Treat Options Neurol 2000, 2:263–274.

    PubMed  Google Scholar 

  69. Richard IH, Kurlan R: A survey of antidepressant drug use in Parkinson’s disease. Parkinson Study Group. Neurology 1997, 49:1168–1170.

    PubMed  CAS  Google Scholar 

  70. Faber R, Trimble MR: Electroconvulsive therapy in Parkinson’s disease and other movement disorders. Mov Disord 1991, 6:293–303.

    Article  PubMed  CAS  Google Scholar 

  71. Fall PA, Ekman R, Granerus AK, et al.: ECT in Parkinson’s disease. Changes in motor symptoms, monoamine metabolites and neuropeptides. J Neural Transm Park Dis Dement Sect 1995, 10:129–140.

    Article  PubMed  CAS  Google Scholar 

  72. Boggio PS, Fregni F, Bermpohl F, et al.: Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson’s disease and concurrent depression. Mov Disord 2005, In press. This study shows that high-frequency rTMS can improve cognition in patients with Parkinson’s disease and depression.

  73. Kanner AM, Palac S: Depression in epilepsy: a common but often unrecognized comorbid malady. Epilepsy Behav 2000, 1:37–51.

    Article  PubMed  Google Scholar 

  74. Mendez MF, Cummings JL, Benson DF: Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986, 43:766–770.

    PubMed  CAS  Google Scholar 

  75. Robertson MM, Trimble MR: Depressive illness in patients with epilepsy: a review. Epilepsia 1983, 24(Suppl 2):S109–116.

    PubMed  Google Scholar 

  76. Batzel LW, Dodrill CB: Emotional and intellectual correlates of unsuccessful suicide attempts in people with epilepsy. J Clin Psychol 1986, 42:699–702.

    Article  PubMed  CAS  Google Scholar 

  77. Gilliam FG, Santos J, Vahle V, et al.: Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction? Epilepsia 2004, 45(Suppl_2):28–33.

    Article  PubMed  Google Scholar 

  78. Pisani F, Spina E, Oteri G: Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 1999, 40(Suppl_10):S48–56.

    Article  PubMed  CAS  Google Scholar 

  79. Settle Jr EC: Antidepressant drugs: disturbing and potentially dangerous adverse effects. J Clin Psychiatry 1998, 59(Suppl_16):25–30.

    PubMed  CAS  Google Scholar 

  80. Rosenstein DL, Nelson JC, Jacobs SC: Seizures associated with antidepressants: a review. J Clin Psychiatry 1993, 54:289–299.

    PubMed  CAS  Google Scholar 

  81. Akamatsu N, Fueta Y, Endo Y, et al.: Decreased susceptibility to pentylenetetrazol-induced seizures after low-frequency transcranial magnetic stimulation in rats. Neurosci Lett 2001, 310:153–156.

    Article  PubMed  CAS  Google Scholar 

  82. Menkes DL, Gruenthal M: Slow-frequency repetitive transcranial magnetic stimulation in a patient with focal cortical dysplasia. Epilepsia 2000, 41:240–242.

    Article  PubMed  CAS  Google Scholar 

  83. Bestmann S, Baudewig J, Siebner HR, et al.: Subthreshold high-frequency TMS of human primary motor cortex modulates interconnected frontal motor areas as detected by interleaved fMRI-TMS. Neuroimage 2003, 20:1685–1696.

    Article  PubMed  Google Scholar 

  84. Ferrarelli F, Haraldsson HM, Barnhart TE, et al.: A [17F]-fluoromethane PET/TMS study of effective connectivity. Brain Res Bull 2004, 64:103–113.

    Article  PubMed  CAS  Google Scholar 

  85. Hilgetag CC, Theoret H, Pascual-Leone A: Enhanced visual spatial attention ipsilateral to rTMS-induced ‘virtual lesions’ of human parietal cortex. Nat Neurosci 2001, 4:953–957.

    Article  PubMed  CAS  Google Scholar 

  86. Oliveri M, Rossini PM, Traversa R, et al.: Left frontal transcranial magnetic stimulation reduces contralesional extinction in patients with unilateral right brain damage. Brain 1999, 122(Pt 9):1731–1739.

    Article  PubMed  Google Scholar 

  87. Burvill PW, Johnson GA, Jamrozik KD, et al.: Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry 1995, 166:320–327.

    PubMed  CAS  Google Scholar 

  88. Wagner T, Fregni F, Eden U, et al.: Transcranial magnetic stimulation and stroke: a computer based human model study. Neuroimage 2005, In press.

  89. Feinstein A: The neuropsychiatry of multiple sclerosis. Can J Psychiatry 2004, 49:157–163.

    PubMed  Google Scholar 

  90. Patten SB, Beck CA, Williams JV, et al.: Major depression in multiple sclerosis: a population-based perspective. Neurology 2003, 61:1524–1527.

    PubMed  CAS  Google Scholar 

  91. Pujol J, Bello J, Deus J, et al.: Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 1997, 49:1105–1110.

    PubMed  CAS  Google Scholar 

  92. Wang JL, Reimer MA, Metz LM, Patten SB: Major depression and quality of life in individuals with multiple sclerosis. Int J Psychiatry Med 2000, 30:309–317.

    Article  PubMed  CAS  Google Scholar 

  93. Schiffer RB, Wineman NM: Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 1990, 147:1493–1497.

    PubMed  CAS  Google Scholar 

  94. Haupts MR, Daum S, Ahle G, et al.: Transcranial magnetic stimulation as a provocation for epileptic seizures in multiple sclerosis. Mult Scler 2004, 10:475–476.

    Article  PubMed  CAS  Google Scholar 

  95. Martis B, Alam D, Dowd SM, et al.: Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol 2003, 114:1125–1132.

    Article  PubMed  Google Scholar 

  96. Moser DJ, Jorge RE, Manes F, et al.: Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology 2002, 58:1288–90.

    PubMed  CAS  Google Scholar 

  97. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998, 88:1337–1342.

    PubMed  CAS  Google Scholar 

  98. Gonzalez-Salvador MT, Arango C, Lyketsos CG, Barba AC: The stress and psychological morbidity of the Alzheimer patient caregiver. Int J Geriatr Psychiatry 1999, 14:701–710.

    Article  PubMed  CAS  Google Scholar 

  99. Lee HB, Lyketsos CG: Depression in Alzheimer’s disease: heterogeneity and related issues. Biol Psychiatry 2003, 54:353–362.

    Article  PubMed  CAS  Google Scholar 

  100. Lyketsos CG, DelCampo L, Steinberg M, et al.: Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry 2003, 60:737–746.

    Article  PubMed  CAS  Google Scholar 

  101. Lyketsos CG, Sheppard JM, Steele CD, et al.: Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer’s disease: initial results from the Depression in Alzheimer’s disease study. Am J Psychiatry 2000, 157:1686–1689.

    Article  PubMed  CAS  Google Scholar 

  102. Magai C, Kennedy G, Cohen CI, Gomberg D: A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer’s disease. Am J Geriatr Psychiatry 2000, 8:66–74.

    Article  PubMed  CAS  Google Scholar 

  103. Petracca G, Teson A, Chemerinski E, et al.: A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 1996, 8:270–275.

    PubMed  CAS  Google Scholar 

  104. Nahas Z, Li X, Kozel FA, et al.: Safety and benefits of distanceadjusted prefrontal transcranial magnetic stimulation in depressed patients 55–75 years of age: a pilot study. Depress Anxiety 2004, 19:249–256.

    Article  PubMed  Google Scholar 

  105. Mottaghy FM, Keller CE, Gangitano M, et al.: Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res 2002, 115:1–14.

    Article  PubMed  Google Scholar 

  106. O’Connor M, Brenninkmeyer C, Morgan A, et al.: Relative effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy on mood and memory: a neurocognitive risk-benefit analysis. Cogn Behav Neurol 2003, 16:118–127.

    Article  PubMed  Google Scholar 

  107. Mayberg HS, Lozano AM, Voon V, et al.: Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651–660.

    Article  PubMed  CAS  Google Scholar 

  108. Alarcon G: Electrical stimulation in epilepsy. Clin Neurophysiol 2005, 116:716–717.

    Article  PubMed  Google Scholar 

  109. Fregni F, Boggio PS, Nitsche M, et al.: Treatment of major depression with transcranial cirect current stimulation. Bipolar Disord 2005, In press.

  110. Fregni F, Boggio PS, Nitsche M, et al.: Anodal transcranial direct current stimulation of prefrontal cortex enhances working memory. Exp Brain Res 2005, In press.

Download references

Author information

Authors and Affiliations

  1. Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, KS 452, 02215, Boston, MA, USA

    Felipe Fregni MD, PhD

Authors
  1. Felipe Fregni MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alvaro Pascual-Leone MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fregni, F., Pascual-Leone, A. Transcranial magnetic stimulation for the treatment of depression in neurologic disorders. Curr Psychiatry Rep 7, 381–390 (2005). https://doi.org/10.1007/s11920-005-0041-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-005-0041-4

Keywords

Search

Navigation